NCT00952068View on ClinicalTrials.gov

A Pharmacodynamic/Pharmacokinetic Study to Determine the Onset of Analgesic Effect and Plasma Levels of Tramadol in Patients With Acute Low Back Pain Receiving a Single 200 mg Dose of Tramadol Contramid® Once-a-Day

PHASE2CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

April 30, 2007

Study Completion Date

April 30, 2007

Conditions
Acute Low Back Pain
Interventions
DRUG

Tramadol Contramid® OAD 200mg

1 Tramadol Contramid® OAD 200mg tablet daily.

Sponsors

Lead Sponsor

Labopharm Inc.
All Listed Sponsors
lead

Labopharm Inc.

INDUSTRY

NCT00952068 - A Pharmacodynamic/Pharmacokinetic Study to Determine the Onset of Analgesic Effect and Plasma Levels of Tramadol in Patients With Acute Low Back Pain Receiving a Single 200 mg Dose of Tramadol Contramid® Once-a-Day | Biotech Hunter | Biotech Hunter